UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients

Critical care (London, England), 2014-12, Vol.18 (6), p.714-714, Article 714

2014

Volltextzugriff (PDF)

Anaphylaxis: Underdiagnosed, Underreported, and Undertreated

The American journal of medicine, 2014, Vol.127 (1), p.S1-S5

2014

Volltextzugriff (PDF)

Joint effects of advancing age and number of potentially inappropriate medication classes on risk of falls in Medicare enrollees

BMC geriatrics, 2019-07, Vol.19 (1), p.194-194, Article 194

2019

Volltextzugriff (PDF)

Anaphylaxis: A Payor's Perspective on Epinephrine Autoinjectors

The American journal of medicine, 2014, Vol.127 (1), p.S45-S50

2014

Volltextzugriff (PDF)

Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration

BMC research notes, 2018-07, Vol.11 (1), p.523-523, Article 523

2018

Volltextzugriff (PDF)

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

Risk management and healthcare policy, 2018-01, Vol.11, p.109-116

2018

Volltextzugriff (PDF)

Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: An assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry

Clinical therapeutics, 2009-01, Vol.31, p.1478-1487

2009

Volltextzugriff (PDF)

Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population

Pharmacotherapy, 2018-04, Vol.38 (4), p.436-443

2018

Volltextzugriff (PDF)

Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?

Expert opinion on drug safety, 2018-05, Vol.17 (5), p.519-523

2018

Volltextzugriff (PDF)

Quantifying Gabapentin Misuse With Opioids

Primary care companion for CNS disorders, 2019-03, Vol.21 (2)

2019

Volltextzugriff (PDF)

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Therapeutics and clinical risk management, 2017-01, Vol.13, p.957-965

2017

Volltextzugriff (PDF)

Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?

General hospital psychiatry, 2008, Vol.30 (1), p.73-76

2008

Volltextzugriff (PDF)

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure

The journal of clinical psychiatry, 2012, Vol.73 Suppl 1 (suppl 1), p.31-36

2012

Volltextzugriff (PDF)

MAOIs: issues in treatment adherence and rates of treatment failure

The journal of clinical psychiatry, 2013, Vol.74 (1), p.e02

2013

Volltextzugriff (PDF)

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

Drug, healthcare and patient safety, 2018-01, Vol.10, p.37-43

2018

Volltextzugriff (PDF)

Introduction: a fresh look at monoamine oxidase inhibitors for depression

The journal of clinical psychiatry, 2012, Vol.73 Suppl 1 (suppl 1), p.3-4

2012

Volltextzugriff (PDF)

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Drugs -- real world outcomes, 2018-03, Vol.5 (1), p.69-79

2018

Volltextzugriff (PDF)

Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United States

Current therapeutic research, 2009-12, Vol.70 (6), p.472-476

2009

Volltextzugriff (PDF)

Selegiline transdermal system: use pattern and adherence in patients with major depressive disorder

Primary care companion for CNS disorders, 2013, Vol.15 (1)

2013

Volltextzugriff (PDF)

Discussion: a fresh look at monoamine oxidase inhibitors for depression

The journal of clinical psychiatry, 2012, Vol.73 Suppl 1 (suppl 1), p.42-45

2012

Volltextzugriff (PDF)

Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson's disease: a national assessment of US office-based physician visits

Journal of parkinsonism & restless legs syndrome, 2017-01, Vol.7, p.79-84

2017

Volltextzugriff (PDF)

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992–1997

Clinical therapeutics, 2000-12, Vol.22 (12), p.1575-1589

2000

Volltextzugriff (PDF)

Authors' response to Letter to the Editor, re: Sclar DA, Robison LM, Gavrun CA Skaer TL. “Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?” General Hospital Psychiatry 2008;30(1):73–76

General hospital psychiatry, 2010-03, Vol.32 (2), p.229-230

2010

Volltextzugriff (PDF)

Quantifying Gabapentin Misuse With Opiods

Primary care companion for CNS disorders, 2019-03, Vol.21 (2)

2019

Volltextzugriff (PDF)

Rate of obesity in U.S. ambulatory patients with diabetes mellitus: A national assessment of office-based physician visits

Primary care diabetes, 2009-08, Vol.3 (3), p.197-199

2009

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(111)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(147)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Humans
(42)
Pharmacology & Pharmacy
(34)
Female
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Male
(19)
Pharmacology. Drug Treatments
(18)
Adult
(17)
Middle Aged
(16)
United States
(16)
Aged
(14)
Depression
(12)
Adolescent
(10)
Drug Therapy
(10)
Medicine, Research & Experimental
(10)
Psychology. Psychoanalysis. Psychiatry
(10)
Research & Experimental Medicine
(10)
Depressive Disorder - Drug Therapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients

Anaphylaxis: Underdiagnosed, Underreported, and Undertreated

Joint effects of advancing age and number of potentially inappropriate medication classes on risk of falls in Medicare enrollees

Anaphylaxis: A Payor's Perspective on Epinephrine Autoinjectors

Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: An assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry

Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population

Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?

Quantifying Gabapentin Misuse With Opioids

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure

MAOIs: issues in treatment adherence and rates of treatment failure

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

Introduction: a fresh look at monoamine oxidase inhibitors for depression

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United States

Selegiline transdermal system: use pattern and adherence in patients with major depressive disorder

Discussion: a fresh look at monoamine oxidase inhibitors for depression

Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson's disease: a national assessment of US office-based physician visits

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992–1997

Authors' response to Letter to the Editor, re: Sclar DA, Robison LM, Gavrun CA Skaer TL. “Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?” General Hospital Psychiatry 2008;30(1):73–76

Quantifying Gabapentin Misuse With Opiods

Rate of obesity in U.S. ambulatory patients with diabetes mellitus: A national assessment of office-based physician visits

Aktive Filter

Suchergebnisse filtern